GSIS
CRL icon

Global Strategic Investment Solutions’s Charles River Laboratories CRL Stock Holding History

Global Strategic Investment Solutions’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Sell
2,698
-40
-1% -$7.12K 0.05% 99
2026
Q1 		$473K Buy
2,738
+40
+1% +$7.42K 0.05% 104
2025
Q4 		$538K Hold
2,698
– – 0.05% 104
2025
Q3 		$422K Hold
2,698
– – 0.04% 113
2025
Q2 		$409K Sell
2,698
-16
-0.6% -$2.13K 0.04% 113
2025
Q1 		$409K Sell
2,714
-3
-0.1% -$503 0.05% 106
2024
Q4 		$502K Hold
2,717
– – 0.06% 102
2024
Q3 		$535K Hold
2,717
– – 0.06% 96
2024
Q2 		$561K Hold
2,717
– – 0.07% 89
2024
Q1 		$736K Hold
2,717
– – 0.09% 79
2023
Q4 		$642K Sell
2,717
-5
-0.2% -$983 0.08% 80
2023
Q3 		$533K Hold
2,722
– – 0.07% 88
2023
Q2 		$572K Buy
2,722
+14
+0.5% +$2.79K 0.07% 86
2023
Q1 		$547K Sell
2,708
-58
-2% -$13.1K 0.08% 81
2022
Q4 		$603K Buy
2,766
+26
+0.9% +$5.68K 0.04% 73
2022
Q3 		$539K Buy
2,740
+1,037
+61% +$224K 0.03% 79
2022
Q2 		$364K Sell
1,703
-1,037
-38% -$253K 0.03% 84
2022
Q1 		$778K Sell
2,740
-49
-2% -$15.1K 0.05% 65
2021
Q4 		$1.05M Buy
2,789
+28
+1% +$10.9K 0.17% 52
2021
Q3 		$1.14M Hold
2,761
– – 0.19% 48
2021
Q2 		$1.02M Hold
2,761
– – 0.17% 51
2021
Q1 		$800K Hold
2,761
– – 0.15% 58
2020
Q4 		$690K Hold
2,761
– – 0.16% 57
2020
Q3 		$625K Hold
2,761
– – 0.16% 54
2020
Q2 		$482K Buy
2,761
+21
+0.8% +$3.35K 0.13% 58
2020
Q1 		$346K Hold
2,740
– – 0.13% 57
2019
Q4 		$419K Hold
2,740
– – 0.15% 39
2019
Q3 		$363K Hold
2,740
– – 0.14% 46
2019
Q2 		$389K Hold
2,740
– – 0.2% 37
2019
Q1 		$398K Hold
2,740
– – 0.22% 34
2018
Q4 		$310K Buy
+2,740
New +$343K 0.26% 36

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Global Strategic Investment Solutions's CRL Position: Q2 2026 in Review

Global Strategic Investment Solutions reduced its Charles River Laboratories (CRL) stake by 1.5% in Q2 2026, selling an estimated $7.12K and leaving 2,698 shares worth $612K. The position accounts for 0.05% of the portfolio, ranked #99.

Global Strategic Investment Solutions first reported a position in CRL in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.14M in Q3 2021. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Global Strategic Investment Solutions held 2,698 shares of Charles River Laboratories worth $612K as of Q2 2026.
  • Global Strategic Investment Solutions sold 40 Charles River Laboratories shares in Q2 2026, an estimated $7.12K.
  • Charles River Laboratories made up 0.05% of Global Strategic Investment Solutions's portfolio in Q2 2026, its #99 holding.
  • Global Strategic Investment Solutions first reported a position in Charles River Laboratories in Q4 2018 and has held it in 31 quarters since.
  • Global Strategic Investment Solutions's Charles River Laboratories position peaked at $1.14M in Q3 2021.
  • 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Global Strategic Investment Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.